Navigation Links
Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
Date:1/8/2010

nts" that involve risks and uncertainties, including, without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these and other risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2009 and filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.

SOURCE Pharmasset, Inc.

RELATED LINKS
http://www.pharmasset.com

'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Fiscal Year End 2009 Financial Results
2. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
3. Pharmasset to Present at Lazard Capital Markets Healthcare Conference
4. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
5. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
6. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
7. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
8. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
9. Pharmasset Reports Fiscal Year End 2008 Financial Results
10. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
11. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... YORK , March 6, 2015  Pomerantz LLP ... Pharmaceuticals Inc. ("Conatus" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... Conatus and certain of its officers and/or directors have ... Act of 1934.  On March 5, ...
(Date:3/6/2015)... --  Hospira, Inc. (NYSE: HSP ), applauds ... today,s FDA approval of the first biosimilar in ... for improving patient access to safe, effective and more affordable ... has seen first-hand the positive impact of biosimilars in other ... stages of the development of a pathway for these medicines ...
(Date:3/6/2015)... Fla. , March 6, 2015 ... special validation from Intuitive Surgical, the manufacturer of ... their Triton-36 Instrument Cleaning System. This approval reflects ... standards in cleanliness currently in place for the ... special validation for reprocessing robotic surgical instruments for ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2
... /PRNewswire-Asia/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, announced today an agreement to acquire ... Ltd. ("Greenlander"). The terms of the agreement were not ... statements. Founded in 2003 and based ...
... Better Health ™, a program of Lilly USA, LLC, (NYSE: ... active lives, has launched an expanded Spanish portal on ... Espanol section features a 60-page interactive health album ... and managing health conditions. Additionally, visitors will find more than ...
Cached Medicine Technology:Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology 2Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology 3Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools 2Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools 3
(Date:3/6/2015)... York, NY (PRWEB) March 06, 2015 ... of “Women’s Health,” a campaign that seeks to educate, ... role when it comes to their health and their ... the rise, it has never been more pertinent to ... rights. , The print component of “Women’s Health” ...
(Date:3/6/2015)... March 06, 2015 As healthcare ... images and content from disparate systems, they are ... care and increase efficiency. Enterprise content management ... content with core IT solutions, including electronic medical ... existing IT applications. , The following organizations ...
(Date:3/6/2015)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Mallory Sofastaii, a mobile ... and shared with viewers how this is a fully immersive ... mobile games have benefited from building in a social media ... to connect their games to Facebook, see what level their ...
(Date:3/6/2015)... Saving Moses, a global humanitarian organization ... traveling to Angola, Africa March 7-14 to visit malnutrition ... , This will be the organizations fifth time to ... commitment to the region’s population by saving infants and ... with the mothers and babies of the malnutrition program, ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... at the Moda Center. After being away from the ... showing no signs of letting up on his “Garth Brooks ... his wife, Trisha Yearwood, to venues around the United States. ... critically acclaimed tour to the Moda Center in Portland, OR. ...
Breaking Medicine News(10 mins):Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3
... Curative ... Therapy Driving Growth, ARCADIA, Calif., Oct. 3 ... Program for Los Angeles, a,ranking of the 50 fastest growing technology, ... Touche USA LLP, one,of the nation,s leading professional services organizations. Rankings ...
... CHICAGO, Oct. 3 President Bush,s veto today,of ... for millions of,children from families with low incomes ... dental health, says Oral Health America, a national,advocacy ... ten million children eligible for coverage through a,bipartisan, ...
... Citys infant mortality rate widely regarded as a barometer ... the Health Department reported today. The rate in 2006 was ... the previous year. The City has made major progress in ... was double what it is today, but the decline has ...
... faculty has received a five-year, $8.4 million grant from ... to survey the genetic, physical and behavioral profiles of ... the reach and ethnic diversity of the Autism Genetic ... research, overseen by Clara Lajonchere, research assistant professor at ...
... WASHINGTON, Oct. 3 The United States,Conference of ... H.,Palmer, today expressed shock and disbelief at President Bush,s ... Insurance Program known as,SCHIP. With his action, 10 million ... protection., "We are extremely disappointed because this is ...
... The California Nurses,Association/National Nurses Organizing Committee today condemned ... Children,s Health Insurance,Program. "Listening to the overheated rhetoric ... Rove may be gone but his legacy lives on," ... Presidents. She chastised,Bush for his recent claims that legislators ...
Cached Medicine News:Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 2Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 3Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 4Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2Health News:New York City's infant mortality rate declined in 2006 2Health News:New York City's infant mortality rate declined in 2006 3Health News:New York City's infant mortality rate declined in 2006 4Health News:USC granted $8.4 million for autism research 2Health News:USC granted $8.4 million for autism research 3Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2
... The CA-1000 counts a Petri dish in ... the optical characteristics of the colonies as ... CA-1000 is equipped with three types of ... lighter or darker than the agar and ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... sophisticated whole blood analysis system that is ... satisfying the stringent requirements of the central ... all of the components of a traditional ... sampling unit, all of the sensors and ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: